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Abstract 
Purpose: In modern radiotherapy techniques such as intensity-modulated radiation therapy (IMRT) and volume 
modulated arc therapy (VMAT), the quality assurance (QA) process is vital. The goal of the study was to verify the 
treatment planning dose delivered during delivery of complex treatment plans. The QA standard is to perform patient-
specific comparisons between planned doses and doses measured in a phantom. 
Materials and Methods: Ninety-five complex IMRT and VMAT plans for different pathologies planned using Eclipse 
treatment planning system (TPS). The Octavius 4D phantom has been used to verify patient specific quality assurance of 
all VMAT plans calculating with different algorithms. 
Conclusion: Overall, good agreement was observed between measured and calculated doses in most cases with gamma 
values above 1 in >95% of measured points in volumetric 3D analysis and 1 in >90% in 2D analysis. The Octavius 4D 
phantom is an effective and efficient method for patient specific QA. 
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Abbreviations: IMRT: Intensity-Modulated Radiation 
Therapy; MLC: Multi-Leaf Collimator; MU: Monitor Unit; 
TPS: Treatment Planning Systems; PTV: Planning Target 
Volume; FiF: Field in Filed; AAA: Anisotropic Analytical 
Algorithm; PDD: Percentage Depth Dose. 
 
Introduction 
Intensity-modulated radiation therapy (IMRT) and 
volumetric modulated arc therapy VMAT) can deliver 
optimal dose distributions delivering prescription doses 
to the target volumes, which are enough to control tumor 
cells, while reducing doses to normal tissues by 
modulating photon beam intensities [1-3]. IMRT 
modulation photon beam intensities by varying the multi-
leaf collimator (MLC) positions. 
 
VMAT modulating the multi-leaf collimator (MLC) 
positions, gantry rotation speed, and dose rates has been 
broadly adopted in the clinic, having benefits of delivering 
prescription dose to target volume while sparing normal 
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tissue. It has shown that VMAT can achieve a similar plan 
quality and monitor unit (MU) effectiveness as compared 
to intensity modulated radiation therapy (IMRT) resulting 
in shortening the treatment time in the clinic [4]. 
Intensity-modulated radiation therapy (IMRT) and VMAT 
can produce highly conformal radiation dose distributions 
and enhance treatment localization. These complex 
treatment techniques also place higher demands on dose 
calculation algorithms in terms of both accuracy and 
computation speed [5,6]. With the increasing popularity 
of IMRT and VMAT techniques in clinics, accuracy in 
treatment planning systems (TPSs) has always been a 
concern in modern radiotherapy. 
 
Dose calculation accuracy is one of the most important 
steps in the radiation therapy treatment process, 
however, the dose calculation process is imperfect due to 
measurement uncertainties, inadequacies in beam 
modeling, and inherent limitations in the algorithms.  
 
The planning process of IMRT and VMAT are not 
intuitive, which is an inverse or forward planning with 
optimization algorithms, and the delivery mechanisms of 
IMRT and VMAT are complex involving various 
mechanical parameters [7,8]. Moreover, calculations of 
the small or irregular fields which are frequently used for 
both IMRT and VMAT are not accurate even with the 
state-of-the-art dose calculation algorithms [9,10]. 
Therefore, there is potential for both IMRT and VMAT to 
cause differences between the calculated dose 
distribution and the actually delivered dose distribution 
to a patient [3]. This can result in unintended treatment 
which is detrimental to patients, which should be avoided. 
In this respect, patient-specific quality assurance QA) for 
every patient treated with IMRT or VMAT technique is 
performed in the clinic before patient treatment [11-13]. 
 
In this study, the pre-treatment patient-specific 
quality assurance for these VMAT cases were completed 
using the OCTAVIUS phantom combined with Detector 
1500 array T10044 (PT W-Freiburg, Freiburg, Germany). 
We analyzed the gamma passing rates in 2D and 3D 
acquired with Octavius phantom for various pathology for 
both IMRT and VMAT. 
 
Materials and Methods 
Measurements were performed with Varian Clinac iX 
accelerators equipped with MLC with a Millennium 120 
multileaf collimator (Varian Medical Systems, Palo Alto, 
CA, USA) using 6 and 18 MV photon beams. 
 
Patients Selection 
Ninety-five patients were included for this study who 
underwent treatment with VMAT technique in our 
institute between February-June 2019. The pathologies 
were 20 patients for each for prostate cancer, head and 
neck, Breast and 15 patients for lung. The lung cancers 
were treated with stereotactic body radiation therapy 
(SBRT) technique. 
 
Dose Calculation and Planning 
All three cases of VMAT plans of patients were 
generated in the Eclipse TPS for a Clinac iX equipped with 
a 120 Millennium MLC. The VMAT plan was created in 
Acuros AXBm. For prostate cases, the total dose 
prescribed to the planning target volume (PTV) was 76 Gy 
with a daily dose of 2.0 Gy in 38 fractions. The prostate 
VMAT plans were generated using two-full-arcs with 6 & 
18 MV photon beams as needed. The head and neck VMAT 
plans were generated by using a two or three-full-arcs 
with 6 MV photon beam and the total prescription dose to 
PTV was 70 Gy (2.0 Gy/fraction). The prostate and head & 
neck cases were treated in simultaneous integrated boost 
(SIB) fractionation schemes. The greatest dose was 
mentioned for the study. The breast cases were treated in 
field in filed (FiF) techniques and the dose to PTV (40.05 
Gy) was given in 15 fractions. The dose to CTV was 10 Gy 
(2Gy/fraction). For lung SBRT cases, prescription dose to 
PTV was 48 Gy in 4 fractions of 80% of isodose. The 
VMAT plans for lung SBRT were made using two-partial-
arcs with 6 MV photon beam. The dose calculation grid 
used in this study was 2.5 mm except for 1.0 mm for lung 
SBRT cases. All the cases were planned by algorithm 
Anisotropic Analytical Algorithm (AAA), Acuros XB (AXB). 
AXB provides two dose reporting modes: dose-to-water 
(AXBw) and dose-to-medium (AXBm). 
 
Octavius Phantom 
The 2D-Array together with Octavius®‐4D (PTW-
Freiburg, Freiburg, Germany) are widely described in the 
literature [14]. Briefly, the 2D-Array 1500 consists of 
1405 vented ionization chambers, each having an 
entrance area of 4.4 x 4.4 mm2 and a height of 3 mm, 
resulting in an ionization volume of 0.058 cm3.The 
chambers are supplied with a voltage of 1000 V. They are 
arranged in rows, and the center-to-center distance 
between the chambers in each row is 10 mm. The 
distance between the rows is 5 mm. A checkerboard 
pattern of the chamber arrangement has been achieved 
by an offset of each second row of chambers, compared 
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with its neighbour rows, of 5 mm in the row direction. 
Thereby, the nearest neighbour distance between 
chambers, measured along the diagonals, is 7.1 mm. This 
arrangement of the chambers results in a spatial sampling 
frequency of 0.1 mm-1 in each row or column and 0.14 
mm-1 in the diagonal direction. By merging two 
measurements with the array shifted by 5 mm in lateral 
or longitudinal direction, the sampling frequency along 
each row and column can be doubled to 0.2 mm-1. The 
manufacturer-specified reference point is 7.5 mm beneath 
the surface and marked at the outer wall of the array.  
 
The 2D-Array 1500 is inserted into a motorized 
cylindrical polystyrene phantom, (diameter and length 32 
cm and 34.3 cm respectively). An inclinometer mounted 
on the gantry ensures that the rotation unit always 
rotates along with the gantry, thus keeping the 2D array 
perpendicular to the beam axis always. The inclinometer 
is connected via wifi to a control unit as shown in fig 1 
that transfers the movement information to the phantom 
and acquires dosimetric data every 200 ms. The beam 
always hits the detector array in a perpendicular way 
because the same face of the detector follows the gantry, 
so no correction factors are required (Figure 1). 
  
 
 
Figure 1: Standard set up of Octavius 4D system in 
measurement position with Detector 1500 inserted in 
a cylindrical phantom that rotates synchronously with 
gantry and the inclinometer attached to gantry. 
 
 
Upon loading this file in the Verisoft software, the 3D 
dose in a homogeneous cylindrical phantom is 
reconstructed: for every stored gantry angle, the 2D 
measurement data are extrapolated to the rest of the 
cylinder by applying a percentage depth dose (PDD) curve 
through every measurement point. The total 3D dose is 
then reconstructed as the sum of these individual 
contributions and linearly interpolated to a user specified 
dose grid. 
 
To evaluate the dosimetric agreement between 
measured and calculated dose, we make use of the gamma 
evaluation method implemented in the Verisoft 7.2.0 
version. This calculation of the gamma index is based on 
the concept of Low, et al. [15]. 
 
Results 
All plans were analyzed using the three parameters, 
the %DA (limit 3%), DTA (limit 3 mm), and g-pass rate 
with the 3% dose tolerance and 3 mm distance to 
agreement in relation to the treatment planning system 
(Table 1). 
 
The 3D dose reconstruction in the Octavius 4D system 
allows the user to select any plane (axial, coronal and 
sagittal) for the evaluation. With the use of Octavius 4D 
system, it is possible to compare and analyze volumetric 
dose field by field or composite field for VMAT in a single 
measurement, thus the user gains confidence about the 
delivery of even complex radiotherapy plans. Potential 
improvements in the device could be achieved with closer 
detector spacing for better resolution. 
 
Figure 2 shows the result of 3 beams SBRT dose map 
in eclipse, calculated dose matrices in Octavius 4D 
phantom and gamma analysis of lung case in transversal, 
sagittal and coronal plane respectively. It should be noted 
that for all plans, our clinical standard of 90% or greater 
for the gamma index percentage was achieved. 
 
All these cases were also studied in portal dosimetry 
and compared to Octavius 4D. These results are not 
presented here Sharma, et al. [16]. Validated the portal 
dosimetry for IMRT in comparison with the results using 
2D ion chamber array with 14 IMRT cases. They 
concluded both 2D ion chamber array and the portal 
dosimetry showed comparable results, therefore, both 
can be used for the patient-specific QA of IMRT Fogliata, 
et al. [17] validated the VMAT technique with portal 
dosimetry by utilizing a total of 275 patient cases. 
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Pathologies 
Gamma passing rates (%) for AAA 
Planar analysis 
Volumetric 3D 
analysis 
2D 
Coronal Sagittal Transversal 
Prostate 95,4 ± 1,2 96,2 ± 0,2 96,8 ± 0,5 97,9 ± 1,1 
Head & neck 97,2 ± 0,8 97,6 ± 1,3 98,1 ± 0,7 98,1 ± 1,2 
Lung 91,8 ± 1,9 91 ± 0,5 94,3 ± 1,3 97,4 ± 1,6 
Breast 95,2 ± 0,8 97,1 ± 1,3 96.8 ± 0,7 98,7 ± 1,3 
Pathologies 
Gamma passing rates (%) for AXBw 
Planar analysis 
Volumetric 3D analysis 2D 
Coronal Sagittal Transversal 
Prostate 95,6 ± 0,4 95,8 ± 1,2 96,2 ± 0,4 97,5 ± 0,5 
Head & neck 96,7 ± 0,3 96,9 ± 0,3 98,2 ± 0,6 98,7 ± 0,3 
Lung 99,1 ± 0,2 99,2 ± 0,3 99,6 ± 0,1 99,7 ± 0,2 
Breast 95,2 ± 0,5 96,1 ± 1,1 96.0 ± 0,3 98,2 ± 1,0 
Pathologies 
Gamma passing rates (%) for AXBm 
Planar analysis 
Volumetric 3D analysis 2D 
Coronal Sagittal Transversal 
Prostate 96,1 ± 1,1 96,2 ± 1,2 97,4 ± 0,5 99,4 ± 0,5 
Head & neck 97,3 ± 1,7 97,8 ± 1,0 97,6 ± 1,1 99,6 ± 0,2 
Lung 94,8 ± 1,2 94,1 ± 1,3 99,6 ± 0,1 99,7 ± 0,2 
Breast 96,1 ± 0,8 96,1 ± 1,1 96.7 ± 1,3 99,2 ± 0,5 
Table 1: summarizes the results of average g-passing rate of different pathologies in our center in 2D and 3D analysis for 
AAA, AXBw and AXBm. The gamma pass rates over all plans were higher than ≤ 97.0 % volumetric 3D analysis. 
 
 
 
Figure 2: A screenshot from Octavius 4D measurements analyzed in Verisoft. Showing the result of 3 beams SBRT 
delivery of lung cases. Panels (a), (b), and (c) show dose map in eclipse, Octavius calculated dose matrices and g-
distribution in transversal, sagittal and coronal plans column wise respectively having 3 beams of SBRT delivery for 
lung case. 
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Discussion 
Results underline that several factors affect plan 
evaluation when using Octavius®‐4D, and they are 
especially enhanced if the more restrictive local γ‐index 
computation approach is used. Indeed, the global γ‐index 
produces more homogeneous results with higher passing 
rates because its tolerance level is computed with respect 
to the value of maximum dose. The 2D approach 
considers each slice as independent of the surrounding 
volume, with the drawback that results are strongly 
dependent on the chosen plane, without a certain 
significant correlation between the magnitude of errors of 
different plans [18]. The 3D analysis allows a 
slice‐by‐slice evaluation taking into account also the 
neighboring slices. Our results confirmed that the single 
slice evaluation (2D) had always a worse agreement 
compared to 3D and volumetric γ‐index. Pulliam [18] 
compared the two gamma results using a Monte Carlo 
computation as reference dose distribution and 
quantified the increase of passing pixels percent up to 
3.2% in the 3D analysis, confirming our findings. 
Conclusion 
The results indicate that Octavius 4D phantom is an 
effective and efficient method for patient specific QA. This 
system is accurate dosimetrically and measurement 
control and three-dimensional analysis that are highly 
adapted to the complexities of modulated irradiation. The 
Octavius 4D phantom is a suitable tool in the dosimetric 
verification of the VMAT and has proven to be fast and 
reliable for patient specific QA. 
 
References 
1. Zhang P, Happersett L, Hunt M, Jackson A, Zelefsky M, 
et al. (2010) Volumetric modulated arc therapy: 
planning and evaluation for prostate cancer cases. 
International Journal of Radiation Oncology Biology 
Physics 76(5): 1456-1462. 
2. Studenski MT, Bar Ad V, Siglin J, Cognetti D, Curry J, 
Tuluc M, et al. (2013) Clinical experience 
transitioning from IMRT to VMAT for head and neck 
cancer. Medical Dosimetry 38(2): 171-175. 
3. Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, 
Mechalakos JG, et al. (2009) IMRT commissioning: 
multiple institution planning and dosimetry 
comparisons, a report from AAPM Task Group 119. 
Medical Physics 36 (11): 5359-5373. 
4. Delivery accuracy of VMAT, The British Journal of 
Radiology. 88: 20140698. 
5. Van Esch A, Tillikainen L, Pyykkonen J, Tenhunen M, 
Helminen H, et al. (2006) Testing of the analytical 
anisotropic algorithm for photon dose calculation. 
Medical Physics 33(11): 4130-4148. 
6. Ding GX, Duggan DM, Coffey CW (2007) Comm ent on 
Testing of the analytical anisotropic algorithm for 
photon dose calculation. Medical Physics 34(8): 3414. 
7. Brahme A (1988) Optimization of stationary and 
moving beam radiation therapy techniques. 
Radiotherapy and Oncology 12(2): 129-140. 
8. Otto K (2008) Volumetric modulated arc therapy: 
IMRT in a single gantry arc. Medical Physics 35(1): 
310-317. 
9. Park JM, Park SY, Kim H (2015) Modulation index for 
VMAT considering both mechanical and dose 
calculation uncertainties. Physics in Medicine & 
Biology 60(18): 7101-7125. 
10. Park SY, Kim IH, Ye SJ, Carlson J, Park JM (2014) 
Texture analysis on the fluence map to evaluate the 
degree of modulation for volumetric modulated arc 
therapy. Medical Physics 41(11): 111718. 
11. Fredh A, Scherman JB, Fog LS, Rosenschold PM(2013) 
Patient QA systems for rotational radiation therapy: a 
comparative experimental study with intentional 
errors. Medical Physics 40(3): 031716. 
12. Heilemann G, Poppe B, Laub W (2013) On the 
sensitivity of common gamma-index evaluation 
methods to MLC misalignments in Rapidarc quality 
assurance. Medical Physics 40(3): 031702. 
13. Kim J, Park SY, Kim HJ, Kim JH, Ye SJ, et al. (2014) The 
sensitivity of gamma-index method to the positioning 
errors of high-definition MLC in patient-specific 
VMAT QA for SBRT. Radiation Oncology 9: 167. 
14. Stathakis S, Myers P, Esquivel C, Mavroidis P, 
Papanikolaou N (2013) Characterization of a novel 2D 
array dosimeter for patient-specific quality assurance 
with volumetric arc therapy. Medical Physics 40(7): 
071731. 
         International Journal of Nuclear Medicine & Radioactive Substances 
 
 
Srivastava RP, et al. Gamma Evaluation with Octavius 4D Phantom for 
Pre-Treatment of Modern Radiotherapy Treatment Techniques. Int J 
Nuclear Med Radioactive Subs 2019, 2(2): 000117.  
             Copyright© Srivastava RP, et al. 
 
6 
15. Low DA, Harms WB, Mutic S, Purdy JA (1998). A 
technique for the quantitative evaluation of dose 
distributions. Medical Physics 25(5): 656-661. 
16. Sharma DS, Mhatre V, Heigrujam M, Talapatra K, 
Mallik S (2010) Portal dosimetry for pretreatment 
verification of IMRT plan: a comparison with 2D ion 
chamber array. Journal of Applied Clinical Medical 
Physics 11(4): 3268. 
17. Fogliata A, Clivio A, Fenoglietto P, Hrbacek J, Kloeck S, 
et al. (2011) Quality assurance of RapidArc in clinical 
practice using portal dosimetry. The British Journal of 
Radiology 84(1002): 534-545. 
18. Pulliam KB, Huang JY, Howell RM, Followill D, Bosca 
R, et al. (2014) Comparison of 2D and 3D gamma 
analyses. Medical Physics 41(2): 021710. 
 
 
